Showing posts with label Diabetes. Show all posts
Showing posts with label Diabetes. Show all posts

Thursday, May 27, 2010

Physical activity or medical treatment

Moral of the story: Which do we target in health campaigns? Why not both?

Source: BMJ

(1) What's more important in the obesity battle – physical activity or medical treatment?
(Head to Head: Should health policy focus on physical activity rather than obesity?)
Yes: http://www.bmj.com/cgi/content/extract/340/may25_1/c2603 No: http://www.bmj.com/cgi/content/extract/340/may25_1/c2602
Experts disagree on bmj.com today about the best way to tackle the obesity crisis. While Professor Louise Baur and colleagues from the Children's Hospital at Westmead and the University of Sydney in Australia acknowledge that "physical inactivity is a major contributor to the global burden of disease," they says that it would be wrong to only focus on this and ignore the problem of obesity.
Baur and colleagues argue that physical inactivity is just one marker and that there is substantial evidence that unhealthy diets low in fibre and high in sugar and large portion size are also responsible for obesity and the diseases associated with it.
However, Dr Richard Weiler, a specialist registrar in sport and exercise medicine at Imperial College Healthcare NHS Trust and general practitioner, and colleagues believe that inadequate cardio-respiratory fitness causes disease more than excess body fat, waist size and body mass index.
Weiler and colleagues maintain that "physical inactivity is one of the greatest health threats facing developed nations today" and they are concerned that 95% of the populations in England and the United States do not meet the recommended guidelines of doing 30 minutes moderate to vigorous physical activity on at least five days a week or equivalent.
They say this is alarming given that physical inactivity rather than obesity per se is an actual cause for many illnesses including obesity, heart disease, type 2 diabetes, mental health problems, high blood pressure and dementia.
Spending huge amounts on treating obesity is not the right way forward, they argue. Weight loss drugs and surgery are risky and the long-term benefits are limited and they certainly do not have the associated health benefits linked to physical activity. They conclude that it is time for health policy and healthcare professionals to focus on fighting physical inactivity, a "chronic disease that has an adult population prevalence of 95%."
Professor Baur, on the other hand, believes that "on its own, improving physical activity will have little impact on reducing overall levels of already established obesity."
She believes that obese people need access to high quality treatment provided by well-trained professionals to deal with their weight and any linked health problems.
In conclusion, Professor Baur and colleagues advocate tackling obesity with a range of strategies, for example, increasing physical activity, improving diet and lifestyles. They say urban planning should be developed to encourage people to use their car less and cycle more and public transport should be made more accessible and affordable.
Contacts:
Louise Baur, The Children's Hospital at Westmead, Sydney, NSW, Australia
Email: louiseb3@chw.edu.au Richard Weiler, Specialist Registrar in Sport and Exercise Medicine, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK and General Practitioner, Hertfordshire Email: c/- cassie.zachariou@imperial.nhs.uk

Wednesday, May 19, 2010

Processed meat may be linked to increased risk of heart disease, diabetes

Moral of the story: Processed meat may the real culprit and unprocessed red meat may be less unhealthy than previously thought. maybe.

Source: AMA Morning Rounds 5/18/2010

Processed meat may be linked to increased risk of heart disease, diabetes.

The Wall Street Journal (5/18, Winslow) reports that processed meat may be linked to increased risk of heart disease and diabetes, according to a study published online in the journal Circulation.
        The Boston Globe (5/17, Cooney) "White Coat Notes" blog reported that investigators looked at data from "20 studies involving more than 1.2 million participants from 10 countries who were followed for up to 18 years." After "pooling the study results, the researchers found that eating unprocessed red meat was not associated with heart disease or diabetes." However, "people who ate at least one serving a day of processed red meat -- one hot dog or two deli slices -- had a 42 percent higher risk of heart disease and a 19 percent higher risk of diabetes than people who did not eat processed red meat."

Sunday, March 21, 2010

Aggressive measures to treat cholesterol, hypertension in diabetes not beneficial.

Moral of the story: The guidelines are correct.  Meet the recommended levels and you are good to go (if you have diabetes).

Source: AMA Morning Rounds 3/17/2010


Aggressive measures to treat cholesterol, hypertension in diabetes not beneficial.


The Los Angeles Times (3/15, Maugh) reports that for diabetics, "two new reports from a major nationwide trial called ACCORD released Sunday show that lowering either blood pressure or cholesterol levels below current guidelines do not provide additional benefit and, in fact, increase the risk of side effects." And, "a third arm of the study, released two years ago, shows that lowering blood sugar levels excessively actually increases the risk of heart disease." Despite being disappointing, "the findings 'reduce the cost and potential side effects of drug therapy' and mean that patients will not have to work as hard at reducing blood sugars, lipids, and blood pressure, said Dr. Denise Simons-Morton of the National Heart, Lung and Blood Institute, which funded the trial."

Wednesday, January 6, 2010

High coffee, tea intake may reduce chances of developing type 2 diabetes

Moral of the story: Drinking coffee and tea reduces chances of developing type II (late onset) diabetes

Source: AMA Morning Rounds 12/15/09;  Arch Intern Med. 2009;169(22):2053-2063.


High coffee, tea intake may reduce chances of developing type 2 diabetes.


Bloomberg News (12/15, Gibson) reports that, according to a study published in the Archives of Internal Medicine, "drinking four cups of coffee, decaf, or tea daily can reduce the chances of getting type 2 diabetes by about 25 percent to 35 percent." Harvard University "researchers reviewed 18 studies of almost 500,000 people" and discovered that "for each cup of coffee people drank, their likelihood of getting diabetes dropped by seven percent."
        "Even better results were found for bigger coffee and tea consumers -- drinking three to four cups a day was associated with about a 25% reduced diabetes risk, compared with those who drank between none and two cups day," the Los Angeles Times (12/15, Stein) reports. In addition, investigators found "positive results with decaf coffee and tea." Specifically, those "who drank more than three to four cups of decaf a day had about a one-third lower risk than those who didn't drink any," while "tea drinkers who consumed more than three to four cups a day had about a one-fifth lower diabetes risk than non-tea drinkers."
        HealthDay (12/14, Gordon) and MedPage Today (12/14, Fiore) also covered the story.

Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type 2 Diabetes Mellitus
A Systematic Review With Meta-analysis
Rachel Huxley, DPhil; Crystal Man Ying Lee, PhD; Federica Barzi, PhD; Leif Timmermeister; Sebastien Czernichow, MD, PhD; Vlado Perkovic, MD, PhD; Diederick E. Grobbee, MD, PhD; David Batty, PhD; Mark Woodward, PhD



Background  Coffee consumption has been reported to be inversely associated with risk of type 2 diabetes mellitus. Similar associations have also been reported for decaffeinated coffee and tea. We report herein the findings of meta-analyses for the association between coffee, decaffeinated coffee, and tea consumption with risk of diabetes.
Methods  Relevant studies were identified through search engines using a combined text word and MeSH (Medical Subject Headings) search strategy. Prospective studies that reported an estimate of the association between coffee, decaffeinated coffee, or tea with incident diabetes between 1966 and July 2009.
Results  Data from 18 studies with information on 457 922 participants reported on the association between coffee consumption and diabetes. Six (N = 225 516) and 7 studies (N = 286 701) also reported estimates of the association between decaffeinated coffee and tea with diabetes, respectively. We found an inverse log-linear relationship between coffee consumption and subsequent risk of diabetes such that every additional cup of coffee consumed in a day was associated with a 7% reduction in the excess risk of diabetes relative risk, 0.93 [95% confidence interval, 0.91-0.95]) after adjustment for potential confounders.
Conclusions  Owing to the presence of small-study bias, our results may represent an overestimate of the true magnitude of the association. Similar significant and inverse associations were observed with decaffeinated coffee and tea and risk of incident diabetes. High intakes of coffee, decaffeinated coffee, and tea are associated with reduced risk of diabetes. The putative protective effects of these beverages warrant further investigation in randomized trials.

Author Affiliations: The George Institute for International Health, The University of Sydney, Sydney, Australia (Drs Huxley, Lee, Barzi, Czernichow, Perkovic, Batty, and Woodward and Mr Timmermeister); Department of Public Health, Avicenne Hospital, University of Paris 13, Paris, France (Dr Czernichow); The Julius Center for Health Sciences and Primary Care, Utrecht University Medical Center, Utrecht, the Netherlands (Dr Grobbee); Medical Research Council Social & Public Health Sciences Unit, University of Glasgow, Glasgow, Scotland (Dr Batty); and Mount Sinai School of Medicine, New York, New York (Dr Woodward).

Sunday, December 6, 2009

Diabetes cases projected to nearly double in next 25 years.

Source: AMA Morning Rounds 11/30/09

Diabetes cases projected to nearly double in next 25 years.


The Chicago Tribune (11/27, Shelton) reported that, according to a study published Nov. 27 in the journal Diabetes Care, "diabetes cases will nearly double in the US in the next 25 years and the cost of treating the disease will almost triple." University of Chicago researchers "found the number of people with diagnosed and undiagnosed diabetes will climb from almost 24 million this year to about 44 million in 2034. Over the same period, annual diabetes-related treatment costs are expected to increase from $113 billion to $336 billion in 2007 dollars."
        Bloomberg News (11/27, Waters) reported, "Diabetes prevents people from breaking down sugar in their blood and can lead to complications, including heart disease, kidney disease, vision loss, and amputation of limbs. While some people have an inherited form of the condition, the majority of cases are linked to obesity."
        HealthDay (11/27, Thomas) reported that, besides obesity, another "factor driving the soaring costs" is "the number of people living with diabetes for lengthy periods, the researchers said. Over time, the cost of caring for someone with diabetes tends to rise along with their risk for developing complications, such as end-stage renal disease, which requires dialysis." Notably, "among Medicare beneficiaries, the number with diabetes is expected to rise from 8.2 million to 14.6 million in 2034, with an accompanying rise in spending from $45 billion to $171 billion."
        "As a result, by 2034, half of all direct spending in diabetes care is projected to occur in the Medicare population," WebMD (11/27, Boyles) reported. Still, "although little can be done about the aging of the population, much can be done about the other major risk factor for type 2 diabetes -- obesity." MedPage Today (11/27, Gever) and CNN (11/27, Hellerman) also covered the study.
        Rituximab seen as promising for type 1 diabetes. Bloomberg News (11/26, Doherty) reported that, according to a study in the Nov. 26 issue of the New England Journal of Medicine, the "arthritis and lymphoma medicine Rituxan [rituximab] cut the need for insulin treatment among patients with type 1 diabetes after a year."
        In a phase 2 trial, researchers from Indiana University randomly assigned "87 patients with newly diagnosed type 1 diabetes...to receive rituximab infusions or a placebo at one-week intervals for four weeks," HealthDay (11/25, Gardner) reported. The investigators discovered that "after one year, C-peptide levels -- an indicator of how much insulin is being produced by the body -- were higher in people taking rituximab versus those in the placebo group," with "those in the rituximab group also" needing "less external insulin." In other words, rituximab "helped patients keep producing some of their own insulin."
        WebMD (11/25, DeNoon) noted, however, that "a single course of Rituxan wasn't enough to stop diabetes. After a year, B cells in treated patients increased to 69% of their original values." Nevertheless, "the study does show that a treatment targeting B cells can preserve beta-cell function in early type 1 diabetes."
        MedPage Today (11/25, Gever) reported that Joel Zonszein, MD, of the Albert Einstein College of Medicine, cautioned, "The molecule [rituximab] is not free of side effects, and" that "important long-term side effects are unknown." Dr. Zonszein, who was not involved in the study, agreed, however, that the "study opens a new pathway of exploration."

Sunday, November 29, 2009

Lack of diabetes knowledge in USA

Moral of the story: go online and look it up if you don't know anything about it. It can kill you.

Source: AMA Morning Rounds 11/3/09

Useful Information:
Your Doctor!
http://www.diabetes.org/
http://diabetes.webmd.com/
http://www.nlm.nih.gov/medlineplus/diabetes.html

Survey suggests many Americans may lack basic knowledge about diabetes.

HealthDay (11/2, Gordon) reported that, according to a survey by the American Diabetes Association, "many Americans lack basic knowledge about" diabetes, a disease "responsible for more deaths each year in the" US "than breast cancer and AIDS combined." The ADA survey "included 2,081 men and women from across the" US, "285 of" whom "been diagnosed with diabetes," finding that one common myth "is that sugar and overeating cause diabetes." However, type 1 diabetes is "an autoimmune disease in which the body mistakenly attacks the islet cells in the pancreas, destroying the body's ability to produce insulin," and "genetics and other unknown factors -- not just diet -- can be contributors" to type 2 diabetes.